110 related articles for article (PubMed ID: 36739077)
1. Empagliflozin mediated miR-128-3p upregulation promotes differentiation of hypoxic cancer stem-like cells in breast cancer.
Nalla LV; Khairnar A
Eur J Pharmacol; 2023 Mar; 943():175565. PubMed ID: 36739077
[TBL] [Abstract][Full Text] [Related]
2. Empagliflozin drives ferroptosis in anoikis-resistant cells by activating miR-128-3p dependent pathway and inhibiting CD98hc in breast cancer.
Nalla LV; Khairnar A
Free Radic Biol Med; 2024 Aug; 220():288-300. PubMed ID: 38734268
[TBL] [Abstract][Full Text] [Related]
3. ZLM-7 inhibits the occurrence and angiogenesis of breast cancer through miR-212-3p/Sp1/VEGFA signal axis.
Li X; Zou ZZ; Wen M; Xie YZ; Peng KJ; Luo T; Liu SY; Gu Q; Li JJ; Luo ZY
Mol Med; 2020 Nov; 26(1):109. PubMed ID: 33187481
[TBL] [Abstract][Full Text] [Related]
4. microRNA-128-3p overexpression inhibits breast cancer stem cell characteristics through suppression of Wnt signalling pathway by down-regulating NEK2.
Chen Y; Wu N; Liu L; Dong H; Liu X
J Cell Mol Med; 2020 Jul; 24(13):7353-7369. PubMed ID: 32558224
[TBL] [Abstract][Full Text] [Related]
5. The highly expressed 5'isomiR of hsa-miR-140-3p contributes to the tumor-suppressive effects of miR-140 by reducing breast cancer proliferation and migration.
Salem O; Erdem N; Jung J; Münstermann E; Wörner A; Wilhelm H; Wiemann S; Körner C
BMC Genomics; 2016 Aug; 17():566. PubMed ID: 27502506
[TBL] [Abstract][Full Text] [Related]
6. LINC00261/microRNA-550a-3p/SDPR axis affects the biological characteristics of breast cancer stem cells.
Li Y; Wu C
IUBMB Life; 2021 Jan; 73(1):188-201. PubMed ID: 33274565
[TBL] [Abstract][Full Text] [Related]
7. Transcription factor SP1-induced microRNA-146b-3p facilitates the progression and metastasis of colorectal cancer via regulating FAM107A.
Wang D; Feng M; Ma X; Tao K; Wang G
Life Sci; 2021 Jul; 277():119398. PubMed ID: 33831429
[TBL] [Abstract][Full Text] [Related]
8. Enforced expression of hsa-miR-125a-3p in breast cancer cells potentiates docetaxel sensitivity via modulation of BRCA1 signaling.
Xu X; Lv YG; Yan CY; Yi J; Ling R
Biochem Biophys Res Commun; 2016 Oct; 479(4):893-900. PubMed ID: 27693788
[TBL] [Abstract][Full Text] [Related]
9. Alteration of miR-362-5p and miR-454-3p expression elicits diverse responses in breast cancer cell lines.
Aarthy R; Rao AKDM; Patel K; Sridevi V; Rajkumar T; Gowda H; Mani S
Mol Biol Rep; 2022 Jan; 49(1):821-826. PubMed ID: 34727290
[TBL] [Abstract][Full Text] [Related]
10. Ginsenoside 20(S)-Rg3 Inhibits the Warburg Effect Via Modulating DNMT3A/ MiR-532-3p/HK2 Pathway in Ovarian Cancer Cells.
Zhou Y; Zheng X; Lu J; Chen W; Li X; Zhao L
Cell Physiol Biochem; 2018; 45(6):2548-2559. PubMed ID: 29558748
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of long non-coding RNA XIST has anticancer effects on epithelial ovarian cancer cells through inverse downregulation of hsa-miR-214-3p.
Wang C; Qi S; Xie C; Li C; Wang P; Liu D
J Gynecol Oncol; 2018 Nov; 29(6):e99. PubMed ID: 30207107
[TBL] [Abstract][Full Text] [Related]
12. Dual-Targeting of miR-124-3p and ABCC4 Promotes Sensitivity to Adriamycin in Breast Cancer Cells.
Hu D; Li M; Su J; Miao K; Qiu X
Genet Test Mol Biomarkers; 2019 Mar; 23(3):156-165. PubMed ID: 30807260
[TBL] [Abstract][Full Text] [Related]
13. miR-142-3p attenuates breast cancer stem cell characteristics and decreases radioresistance in vitro.
Troschel FM; Böhly N; Borrmann K; Braun T; Schwickert A; Kiesel L; Eich HT; Götte M; Greve B
Tumour Biol; 2018 Aug; 40(8):1010428318791887. PubMed ID: 30091683
[TBL] [Abstract][Full Text] [Related]
14. Chemotherapy-elicited exosomal miR-378a-3p and miR-378d promote breast cancer stemness and chemoresistance via the activation of EZH2/STAT3 signaling.
Yang Q; Zhao S; Shi Z; Cao L; Liu J; Pan T; Zhou D; Zhang J
J Exp Clin Cancer Res; 2021 Apr; 40(1):120. PubMed ID: 33823894
[TBL] [Abstract][Full Text] [Related]
15. Hsa_circ_0002082 up-regulates Centromere Protein F via abolishing miR-508-3p to promote breast cancer progression.
Liu Y; Liu Y; Luo J; Zhao W; Hu C; Chen G
J Clin Lab Anal; 2022 Nov; 36(11):e24697. PubMed ID: 36161346
[TBL] [Abstract][Full Text] [Related]
16. LncRNA HOTTIP facilitates the stemness of breast cancer via regulation of miR-148a-3p/WNT1 pathway.
Han L; Yan Y; Zhao L; Liu Y; Lv X; Zhang L; Zhao Y; Zhao H; He M; Wei M
J Cell Mol Med; 2020 Jun; 24(11):6242-6252. PubMed ID: 32307830
[TBL] [Abstract][Full Text] [Related]
17. MZF1 Transcriptionally Activated MicroRNA-328-3p Suppresses the Malignancy of Stomach Adenocarcinoma via Inhibiting CD44.
Qi Z; Wang J; Li Y; Xu Y
J Immunol Res; 2022; 2022():5819295. PubMed ID: 35669102
[TBL] [Abstract][Full Text] [Related]
18. Circular RNA hsa_circ_0043278 inhibits breast cancer progression via the miR-455-3p/EI24 signalling pathway.
Shi Y; Liu C
BMC Cancer; 2021 Nov; 21(1):1249. PubMed ID: 34800978
[TBL] [Abstract][Full Text] [Related]
19. LncRNA SPRY4-IT1 regulates breast cancer cell stemness through competitively binding miR-6882-3p with TCF7L2.
Song X; Zhang X; Wang X; Chen L; Jiang L; Zheng A; Zhang M; Zhao L; Wei M
J Cell Mol Med; 2020 Jan; 24(1):772-784. PubMed ID: 31736268
[TBL] [Abstract][Full Text] [Related]
20. Hsa_circ_0053063 inhibits breast cancer cell proliferation via hsa_circ_0053063/hsa-miR-330-3p/PDCD4 axis.
Ji C; Hu J; Wang X; Zheng W; Deng X; Song H; Yu Y; Luo Q; Hua K; Zhou X; Fang L
Aging (Albany NY); 2021 Mar; 13(7):9627-9645. PubMed ID: 33744861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
